Advancing Innovation in Alternative Pain and Addiction Therapies Act
This bill requires the Food and Drug Administration to issue guidance clarifying eligibility and criteria for the accelerated approval of non-opioid or nonaddictive drugs to treat pain or substance-use disorders.